VYNE – vyne therapeutics inc. (US:NASDAQ)

News

VYNE Therapeutics (NASDAQ:VYNE) was upgraded by analysts at Wall Street
VYNE Therapeutics (NASDAQ:VYNE) was downgraded by analysts at Wall Stree
VYNE Therapeutics (NASDAQ:VYNE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights
Shareholder Alert: The Ademi Firm investigates whether VYNE Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com